ID | 1218 |
Name of the vaccine | ACAM2007 |
Microbe | Bacteria |
Disease name | E.coli Infections |
Name of bacteria | Escherichia coli |
Type of vaccine | Live attenuated |
Nucleic acid content | Circular duplex DNA |
Age | 18 to 49 years |
Description of the vaccine | CFA/II expressing ETEC vaccine. |
Name of the manufacturer | NA |
Name of the manufacturing country | London |
Year of manufacture | NA |
Clinical Phase status | Clinical - Phase 1 |
Bacterial strain | Gram-negative, rod-shaped bacteria. |
Efficacy | NA |
Vaccine formulation | NA |
Dosage | One or two doses. |
Mechanism of action | ASC, ALS, serology, WGLF and serum IgA. |
Route of administration | Oral |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | NA |
Repurposing | NA |
Side effects of vaccine | Non-serious adverse events. |
Post vaccination | NA |
Dose type | Both |
Interspecies transfer | NA |
PubMed identifier | 17566016 |
Clinical trial number | NA |
Reference | http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=115&keywords= |
Other name | NA |
Additional Links | NA
|